AXIS Capital upgraded by Keefe Bruyette with a new price target
$AXS
Property-Casualty Insurers
Finance
Keefe Bruyette upgraded AXIS Capital from Mkt Perform to Outperform and set a new price target of $66.00 from $59.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/13/2025 | $93.00 | Market Perform | BMO Capital Markets |
| 12/11/2024 | $78.00 → $89.00 | Underweight → Equal Weight | Wells Fargo |
| 10/4/2024 | $118.00 | Buy | TD Cowen |
| 11/13/2023 | $59.00 → $66.00 | Mkt Perform → Outperform | Keefe Bruyette |
| 9/15/2023 | $53.00 → $68.00 | Underperform → Buy | BofA Securities |
| 9/8/2023 | $51.00 | Sell | Goldman |
| 12/19/2022 | $63.00 → $60.00 | Outperform → Mkt Perform | Keefe Bruyette |
| 12/16/2022 | $55.00 | Equal Weight → Underweight | Wells Fargo |
AXIS Capital Holdings Limited ("AXIS Capital" or "AXIS" or the "Company") (NYSE:AXS) today announced Sara Farrup (nee Mitchell) has assumed the role of Head of Global Markets as part of a planned leadership transition, first announced in September 2024. Ms. Farrup, who reports to AXIS President and CEO Vince Tizzio and is part of the Company's Executive Committee, succeeds longtime Head of Global Markets Mark Gregory, who will continue to serve as a strategic advisor to the Company through March. Ms. Farrup is based in the Company's London office. "I am proud to join AXIS as Head of Global Markets at this exciting point in the Company's journey," commented Ms. Farrup. "I feel privileged t
AXIS Capital Holdings Limited ("AXIS Capital" or "AXIS" or the "Company") (NYSE:AXS) today announced that Pranav Shroff has joined the Company as Head of Life Sciences in North America. Mr. Shroff will lead the development of a suite of specialty coverages in support of the life sciences industry, with an initial focus on Products Liability, Professional Liability, and Clinical Trials Liability. His responsibilities include executing on the underwriting strategy, cultivating relationships with our distribution partners in this specialty segment, and building a team to support this initiative. Bringing extensive underwriting experience and knowledge of life sciences, Mr. Shroff joins AXIS
AXIS Capital Holdings Limited ("AXIS Capital") (NYSE:AXS) today announced that W. Marston (Marty) Becker will succeed Henry B. Smith as non-executive Chair of its Board of Directors. Mr. Smith, who has served as Chair since May of 2020, has decided to transition from the Chair role and will continue to maintain a seat on the Board. The transition will take place in May of 2024, timed to the Company's Annual General Meeting. "There is no better individual to succeed me as Chair of the AXIS Board of Directors than Marty Becker. Over the past four years, the Company has benefitted enormously from Marty's wisdom, and deep understanding of the specialty property and casualty space," said Mr. S
4 - AXIS CAPITAL HOLDINGS LTD (0001214816) (Issuer)
4 - AXIS CAPITAL HOLDINGS LTD (0001214816) (Issuer)
4 - AXIS CAPITAL HOLDINGS LTD (0001214816) (Issuer)
BMO Capital Markets initiated coverage of AXIS Capital with a rating of Market Perform and set a new price target of $93.00
Wells Fargo upgraded AXIS Capital from Underweight to Equal Weight and set a new price target of $89.00 from $78.00 previously
TD Cowen initiated coverage of AXIS Capital with a rating of Buy and set a new price target of $118.00